By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

AbGenomics Corporation 

2F, No. 36, Ln. 358, Juikuang Road

Neihu  Taipei  114  Taiwan
Phone: 886-2-2627-2707 Fax: 886-2-2627-2708


SEARCH JOBS


Industry
Biotechnology






Company News
AbGenomics Corporation Announces IND Filing For Abgn-168H (Neihulizumab) To Treat Psoriatic Arthritis 10/17/2014 7:18:20 AM
Los Altos' AbGenomics Corporation Locks In $16 Million 10/6/2014 7:08:16 AM
AbGenomics Corporation Has Raised $9.6 Million for Advancing Its Psoriasis Phase-II Trials in U.S. 7/18/2013 6:46:07 AM
AbGenomics Corporation Obtains FDA Agreement on Its Phase 2 Clinical Trial Plans 8/20/2012 10:52:54 AM
AbGenomics Corporation Obtains FDA Agreement on Its Phase 2 Clinical Trial Plans 8/20/2012 10:51:20 AM
AbGenomics Corporation Regains Global Rights to AbGn-168H from Boehringer Ingelheim Corporation 12/19/2011 6:30:52 AM
Crucell N.V. (CRXL) And DSM Biologics Announce PER.C6(R) License Agreement With AbGenomics Corporation 1/11/2007 4:11:46 PM
Boehringer Ingelheim GmbH And AbGenomics Corporation Sign Worldwide Exclusive Collaboration And License Agreement To develop And Commercialize A Therapeutic Monoclonal Antibody10/19/2005 5:09:20 PM
//-->